» Articles » PMID: 10857795

The Familial Form of Spondylarthropathy: a Clinical Study of 115 Multiplex Families. Groupe Français D'Etude Génétique Des Spondylarthropathies

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2000 Jun 17
PMID 10857795
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the interrelationships among different phenotypes, and their relationship to the HLA-Blocus, in multiplex families with spondylarthropathy (SpA).

Methods: We recruited 115 white French families, each of which had at least 2 members with SpA. Pedigrees were established. Clinical data and pelvic radiographs were collected. The HLA-B27 status of all patients was determined. Analysis was performed to determine the prevalence of SpA manifestations according to sex, disease duration, and HLA-B status, and to examine clustering of specific manifestations in subsets of families.

Results: We identified 329 SpA patients. Mean +/-SD age at onset was 24+/-9.4 years. The male:female ratio was 186:143, or 1.3, with few sex differences in disease expression. Axial manifestations and HLA-B27 were each present in 97% of the patients. Inflammatory bowel disease and HLA-B35 were overrepresented in the 7 families containing HLA-B27-negative patients. The frequency of radiographic sacroiliitis increased in parallel with disease duration. Peripheral enthesitis, radiographic sacroiliitis, and psoriasis were evenly distributed in the families. Clustering independent of age was only observed for peripheral arthritis, suggesting that specific factors may predispose individuals to this manifestation.

Conclusion: Familial SpA appears to be homogeneous, based on the high frequencies of axial skeletal involvement and HLA-B27. The lack of clustering of most manifestations in families suggests that a predominant shared component, including HLA-B27, predisposes individuals to all forms of familial SpA, and that ubiquitous genetic or environmental factors contribute to phenotype diversity.

Citing Articles

Large-Scale Genetic Correlation Analysis between Spondyloarthritis and Human Blood Metabolites.

Yang M, Xu J, Zhang F, Luo P, Xu K, Feng R J Clin Med. 2023; 12(3).

PMID: 36769847 PMC: 9917834. DOI: 10.3390/jcm12031201.


Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients.

Berland M, Meslier V, Berreira Ibraim S, Le Chatelier E, Pons N, Maziers N Arthritis Rheumatol. 2022; 75(1):41-52.

PMID: 35818337 PMC: 10099252. DOI: 10.1002/art.42289.


A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics.

Lee S, Kang S, Eun Y, Won H, Kim H, Cha H Arthritis Res Ther. 2021; 23(1):284.

PMID: 34782006 PMC: 8591959. DOI: 10.1186/s13075-021-02647-z.


Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study.

Boel A, Lopez-Medina C, van der Heijde D, van Gaalen F Rheumatology (Oxford). 2021; 61(4):1468-1475.

PMID: 34260699 PMC: 8996784. DOI: 10.1093/rheumatology/keab544.


Ultrasound-Verified Peripheral Arthritis in Patients with Positive Spondyloarthritis.

Soso D, Aljinovic J, Lovric Kojundzic S, Marinovic I, cecuk Jelicic E, Marasovic Krstulovic D Life (Basel). 2021; 11(6).

PMID: 34199710 PMC: 8228545. DOI: 10.3390/life11060524.